FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 96 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $24,761,000 | +3402.3% | 657,354 | +1481.5% | 0.00% | – |
| Q4 2020 | $707,000 | +924.6% | 41,565 | +183.0% | 0.00% | – |
| Q3 2020 | $69,000 | -50.4% | 14,689 | -35.4% | 0.00% | – |
| Q2 2020 | $139,000 | +2.2% | 22,737 | -62.2% | 0.00% | – |
| Q1 2020 | $136,000 | -42.6% | 60,174 | +16.2% | 0.00% | – |
| Q4 2019 | $237,000 | -62.0% | 51,787 | -67.9% | 0.00% | – |
| Q3 2019 | $624,000 | -59.9% | 161,180 | -37.6% | 0.00% | – |
| Q2 2019 | $1,558,000 | +470.7% | 258,317 | +1167.3% | 0.00% | – |
| Q1 2019 | $273,000 | -62.0% | 20,384 | -73.6% | 0.00% | – |
| Q4 2018 | $718,000 | -22.2% | 77,107 | +16.4% | 0.00% | – |
| Q3 2018 | $923,000 | -41.6% | 66,269 | -33.7% | 0.00% | – |
| Q2 2018 | $1,581,000 | -2.8% | 99,950 | +5.5% | 0.00% | – |
| Q1 2018 | $1,627,000 | -78.9% | 94,705 | -73.1% | 0.00% | -100.0% |
| Q4 2017 | $7,709,000 | +253.8% | 351,666 | +560.2% | 0.00% | +100.0% |
| Q3 2017 | $2,179,000 | -47.1% | 53,267 | -61.1% | 0.00% | 0.0% |
| Q2 2017 | $4,117,000 | -53.2% | 136,776 | -43.8% | 0.00% | 0.0% |
| Q1 2017 | $8,798,000 | -18.7% | 243,368 | +12.7% | 0.00% | -50.0% |
| Q4 2016 | $10,818,000 | +533.4% | 215,868 | +564.0% | 0.00% | +100.0% |
| Q3 2016 | $1,708,000 | +315.6% | 32,510 | +227.0% | 0.00% | – |
| Q2 2016 | $411,000 | -80.9% | 9,942 | -81.2% | 0.00% | -100.0% |
| Q1 2016 | $2,152,000 | +389.1% | 52,966 | +399.5% | 0.00% | – |
| Q4 2015 | $440,000 | +151.4% | 10,603 | -6.6% | 0.00% | – |
| Q3 2015 | $175,000 | -63.9% | 11,348 | -41.9% | 0.00% | – |
| Q2 2015 | $485,000 | -72.4% | 19,547 | -74.6% | 0.00% | -100.0% |
| Q1 2015 | $1,757,000 | +854.9% | 76,865 | +1028.0% | 0.00% | – |
| Q4 2014 | $184,000 | -31.6% | 6,814 | -70.3% | 0.00% | – |
| Q3 2014 | $269,000 | -3.9% | 22,921 | +27.4% | 0.00% | – |
| Q2 2014 | $280,000 | +164.2% | 17,987 | +235.5% | 0.00% | – |
| Q1 2014 | $106,000 | +1225.0% | 5,362 | +1063.1% | 0.00% | – |
| Q4 2013 | $8,000 | – | 461 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|